［1］卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究.北京：人民卫生出版社，1979.

［2］全国肿瘤防治研究办公室.中华人民共和国恶性肿瘤地图集.北京：中国地图出版社，1979.

［3］同济医科大学.中国人口主要死因地图集.北京：中国地图出版社，1990.

［4］陈君石，柯林•坎贝尔，黎钧耀，理查德•皮托.中国膳食、生活方式与死亡率——六十五个县的调查研究. Oxford University Press，Cornell University Press，People's Medical Publishing House，1990.

［5］王陇德：中国居民营养与健康状况调查报告之一2002综合报告.北京：人民卫生出版社，2005.

［6］何兴舟，杨儒道.室内燃煤空气污染与肺癌.昆明：云南科技出版社，1994.

［7］尹松年，查德•赫司，李桂兰，等.苯的流行病学与毒理学研究论文集（II）.北京：中国疾病预防控制中心卫生与中毒控制所出版社，2006.

［8］黎钧耀.国内外癌症预防对策和措施研究进展.中华医学会1985年第二届全国肿瘤学术会议汇编，天津：1-17，1985.

［9］黎钧耀.解密我国癌症归因，为防控策略导航.中国医学论坛报肿瘤B6，2012-07-26.

［10］黎钧耀.癌症的营养干预研究.化学进展，2013，25（9）：1462-1479.

［11］陈竺.全国第三次死因回顾抽样调查报告.北京：中国协和医科大学出版社，2008.

［12］董志伟.中国癌症研究进展（第七卷）：中国主要癌症的筛查及早诊早治.北京：北京大学医学出版社，2004.

［13］董志伟.中国癌症研究进展（第八卷）——中国癌症高发现场防治工作.北京：北京大学医学出版社，2007.

［14］张思维，陈万青，王乐.中国肿瘤登记工作30年.中国肿瘤，2009，18（4）：256-259.

［15］杨文献.中国林州市食管癌高发区人群病因学预防效果观察.中国肿瘤，2008，17（7）：548-552.

［16］陈建国.启东癌症报告：1972-2011.北京：军事医学科学出版社，2013.

［17］游伟程.胃癌流行病学研究进展.中华预防医学杂志，33：49-51，1999.

［18］袁媛.辽宁省庄河地区胃癌高发现场高危人群综合防治研究.中国肿瘤，2005，14（5）：3107-3111.

［19］郑树，刘希水.我国大肠癌筛检推荐方案的建立与实践.中国癌症研究进展：31-37，北京：军事医学科学出版社，2000.

［20］胡宏雷，董时富.幽门螺杆菌感染与胃癌关系的meta分析.中国卫生统计，2006，23（1）：65-67.

［21］陈建国.恶性肿瘤高发现场工作的发展与建议.中国肿瘤，2005，14（5）：294-296.

［22］杨学志，汤胜兰，廖彩森等.江西靖安县宫颈癌队列研究.中华肿瘤杂志，1991，13（6）：409-411.

［23］赵方辉，乔友林.子宫颈癌疫苗研究进展.流行病学进展，2010，12：70-79.

［24］黎钧耀，布洛特，李冰，等.中国林县居民癌症和其他常见病营养预防试验效果初步报告.中华肿瘤杂志，1993，15（3）：165-179.

［25］曾毅，商铭，刘纯仁，等.中国八个省市鼻咽癌病人EB病毒壳抗原的免疫球蛋白的A抗体的测定.中华肿瘤杂志，1979，1（2）：8-11.

［26］曾毅，张芦光，吴映成，等.广西梧州市EB病毒IgA/VCA抗体阳性者的追踪观察.病毒学报，1985，1（1）：7-12.

［27］李锦添，宗永生.上皮异型性增生和鳞状化生在鼻咽癌组织发生中关系的探讨.中山医学院学报，1985，6（2）：21-24.

［28］钟建明，曾毅，廖建等. Epstein-Barr病毒IgA/VCA抗体变动规律和鼻咽癌发病的关系.中华实验和临床病毒学杂志，1996，10（3）：225-226.

［29］李兰娟.感染微生态学研究.公共卫生与预防医学学科发展报告（2011-2012）. 74-81.北京：中国科学技术出版社，2012.

［30］陈伟，项永兵.体质指数与肺癌关系的流行病学研究进展.中国肿瘤，2009，18（4）：294-297.

［31］Ahn J，Sinha R，Pei Z，et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst，2013，105：1907-1911.

［32］American Society of Clinical Oncology. Accelerating progress against cancer. ASCO's Blueprint for Transforming Clinical and Translational Cancer Research. ASCO，2011.

［33］Belinson JL，Qiao YL，Pretorius RG，et al. Shanxi province cervical cancer screening study：across sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol. Oncol，2001，83，439-444.

［34］Blot WJ，Li JY，Taylor PR，et al. The Linxian Trials：mortality rates by vitamin/mineral intervention group. Am J Clin Nutr 1995，62（suppl）：1424S-1426S.

［35］Chen JG，Egner PA，Ng D，et al：Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res（Phila）. 2013，6（10）：1038-1045.

［36］Chen T，Yan F，Qian J，Guo M，et al. Randomized PhaseⅡTrial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus. Cancer Prev Res，2012，5：41-50.

［37］de Villiers EM，Lavergne D，Chang F，et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer，1999，81：225-228.

［38］Egner PA，Chen JG，Wang JB，et al. Bioavailability of sulforaphane from two broccoli sprout beverages：results of a shortterm，cross-over clinical trial in Qidong，China. Cancer Prev Res，2011，4：384-395.

［39］Gao Y，Den J，Xiang Y，et al：Smoking，related cancers，and other diseases in Shanghai：a 10-year prospective study. Zhonghua Yu Fang Yi Xue Za Zhi，1999 33：5-8.

［40］Gao YT，McLaughlin JK，Blot WJ，et al：Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst，1994，86：855-858.

［41］Gu DF，Kelly TN，Wu XG，et al. Mortality attributable to smoking in China. N Engl J Med，2009，360：150-159.

［42］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 95）：Household use of solid fuels and high-temperature frying/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2006.

［43］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 95）：Alcohol consumption and ethyl carbamate/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2007.

［44］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100B）：Biological agents/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.

［45］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100C）：Arsenic，metals，fibres，and dusts/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.

［46］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100D）：Radiation/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.

［47］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100E）：Personal habits and indoor combustions/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.

［48］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100F）：Chemical agents and related occupations/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.

［49］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 101）：Some chemicals present in industrial and consumer products，food and drinking-water/IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.

［50］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 102）：Non-ionizing radiation，PartⅡ：Radiofrequency electromagnetic fields/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.

［51］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 103）：Bitumens and bitumen emissions，and some N-and S-heterocyclic aromatic hydrocarbons/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.

［52］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 104）：Malaria and some Polyomaviruses（SV40，BK，JC，and Merkel cell viruses）/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

［53］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 105）：Diesel and gasoline engine exhausts and some nitroarenes/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2012.

［54］Jian L，Xie LP，Lee AH，Binns CW. Protective effect of green tea against prostate cancer：A case control study in southeast China. Int J Cancer，2004，108：130-135.

［55］Kensler TW，Chen JG，Egner PA，et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthene tetraols in a randomized clinical trial in He Zuo Township，Qidong，PRC. Cancer Epidemiol Biomarkers Prev，2005，14：2605-2613.

［56］Kensler TW，Ng D，Carmella SG，et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong，China. Carcinogenesis，2012，33： 101-107.

［57］King HT，Li JY，Loche FB，et al. Patterns of Site-Specific Displacement in Cancer Mortality among Migrants：The Chinese in the United States. American J Public Health，1985，75（3）：237-242.

［58］Kurmi OP，Arya PH，Lam KBH，et al. Lung cancer risk and solid fuel smoke exposure：a systematic review and meta-analysis. Eur Respir J，2012，40：1228-1237.

［59］Lam KY，He D，Ma L，et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum. Pathol，1997，28，657-663.

［60］Lan Q，Chapman RS，et al. Household stove improvement and risk of lung cancer in Xuanwei，China. J National Cancer Institute，2002，94（11）：826-835.

［61］Lee SA，Shu XO，Li H，et al. Adolescent and adult soy food intake and breast cancer risk：results from the Shanghai Women's Health Study. Am J Clin Nutr，2009，89：1920-1926.

［62］Leeson N. Potential immune-avoidance mechanism found in RNA virus. Future Virology，2014，9（2）：107-109.

［63］Li B，Taylor PR，Li JY，et al. Linxian nutrition intervention trials：design，methods，participant characteristics and compliance. Annals of Epidemiology，1993，3（6）：577-585.

［64］Li JY，Li B，Blot WJ，et al. Preliminary report on the results of Nutrition Prevention Trials of Cancer and Other Common Diseases Among Residents in Linxian，China. Chinese Medical Journal，1995，108（10）：780.

［65］Yuan JM，Gao YT，Yang CS，et al. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer，2007 120：1344-1350.

［66］Li JY，Taylor PR，Li B，et al. Nutrition intervention trials in Linxian，China：multiple vitamin/mineral supplementation，cancer incidence，and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst，1993，85（18）：1492-1498.

［67］Li JY. Preliminary Report on Chemopreventive Trial Effects of Cancer and some Commonly seen Diseases. Monograph of Academic Papers in the 1994 Scientific Annual Meeting（Eds. Scientific Branch of the CAMS and PUMC，Published）：49-60，1994.

［68］Li L，Ji J，Wang JB，et al. Attributable causes of breast cancer and ovarian cancer in China：reproductive factors，oral contraceptives and hormone replacement therapy. Chin J Cancer Res，2012，24：9-17.

［69］Li T，Lu ZM，Chen KN，et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis，2001，22，929-934.

［70］Li T，Lu ZM，Guo M，et al. p53 Codon 72 polymorphism（C/G）and the risk of human papillomavirusassociated carcinomas in China. Cancer，2002，95：2571-2576.

［71］Li W，Zhu Y，Yan X，et al. The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi，2000，34：336-338.

［72］Liang H，Wang J，Xiao H，et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in china. BMC Public Health. 2010，10：730.

［73］Liu BQ，Peto R，Chen ZM，et al. Emerging tobacco hazards in China：Retrospective proportional mortality study of one million deaths. BMJ，1998，317：1411-1422.

［74］Makar GA，Holmes JH，Yang YX. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst，2014，106（2）：1-8.

［75］Mulcahy N. ASCO adds oomph to breast cancer chemoprevention guide：Will it make any difference? Medscape Medical News. July 8，2013.

［76］Qiao YL，Dawsey SM，Kamangar F，et al. Total and Cancer Mortality After Supplementation With Vitamins and Minerals：Follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst. 2009，101：507-518.

［77］Shiels MS，Pfeiffer RM，Hildesheim A，et al. Circulating Inflammation Markers and Prospective Risk for Lung Cancer. J Natl Cancer Inst，2013，105：1871-1880.

［78］Shu XO，Jin F，Dai Q，et al. Soy food intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev，2001，10：483-488.

［79］Si HX.，Tsao，SW，Poon CS，et al. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer，2003，103，496-500.

［80］Sperduto RD，Hu TS，Milton RC，et al. The Linxian Cataract Studies：Two Nutrition Trials. Archives of Ophthalmology 111：1246-1253，1993.

［81］Stefanek ME，Andrykowski MA，Lerman C，et al：Behavioral Oncology and the War on Cancer：Partnering with Biomedicine. Cancer Res，2009，69：7151-7156.

［82］Sun CL，Yuan JM，Lee MJ，et al. Urinary tea polyphenols in relation to gastric and esophageal cancers：a prospective study of men in Shanghai，China. Carcinogenesis. 2002，23：1497-1503.

［83］Sun ZT，Chen TY，Thorgeirsson3 SS，et al. Dramatic reduction of liver cancer incidence in young adults：28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis，2013，34（8）：1800-1805.

［84］Thompson PA. Genome-wide Association Studies Meet Chemoprevention. JNCI J Natl Cancer Inst，2013，105（24）：1847-1848.

［85］Tsoref D，Panzarella T，Oza A. Aspirin in Prevention of Ovarian Cancer：Are We at the Tipping Point? J Natl Cancer Inst 106，2014，（2）：1-2.

［86］Visvanathan K，Hurley P，Bantug E，et al. Use of pharmacologic interventions for breast cancer risk reduction：American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol，2013，31：2942-2962.

［87］Wang D，Zheng W，Wang SM，et al. Estimation of cancer incidence and mortality attributable to overweight，obesity，and physical inactivity in China. Nutr Cancer，2012，64：48-56.

［88］Wang JB，Jiang Y，Liang H，et al. Attributable causes of cancer in China. Ann Oncol，2012，23（11）：2983-2989.

［89］Wang JB，Jiang Y，Wei WQ，et al. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control，2010，21：959-965.

［90］Wang X，Lin S，Yu I et al. Cause-specific mortality in a Chinese chrysotile textile worker cohort. Cancer Sci，2013，104：245-249.

［91］Xiang W，Shi JF，Li P，et al. Estimation of cancer cases and deaths attributable to infection in China. Cancer Causes Control，2011，22：1153-1161.

［92］Xiao HJ，Liang H，Wang JB，et al. Attributable causes of cancer in china：fruit and vegetable. Chin? J Cancer Res，2011，23：171-176.

［93］Yu SY，Zhu YJ，Li WG，et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res，1991，29：289-294.

［94］Yu SY，Zhu YJ，Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res，1997，56：117-124.